Positive: We view this as a major milestone for AVZ and its...

Positive:

We view this as a major milestone for AVZ and its shareholders and partners. With the ministerial decree, AVZ will be able to complete its agreement with strategic investor and partner CATH bringing in $240 MM to accelerate construction and keeping to its timeline of first spodumene production in late 2023. We view the challenges to ownership interests as a distraction and expect them to be resolved in the near-term with no negative impact to AVZ. As such, we view the recent sell-off in the stock as a buying opportunity.

We maintain our Speculative Buy rating and $1.00 target price.

Says it all doesn’t it

Wonder how much they will make off weak hands and stops this time…

I guess if you can’t beat them….

Anyone wanna buy a boat ? I need to free up some cash


GLTAH